Biotechnology Industry Research Assistance Council (BIRAC) is working on setting up the “National Biopharmaceutical Acceleration Program”. This Program is focused on fast-tracking the process of preparing India’s capabilities in translational life science research such that India emerges as a hub for design and development of novel, affordable and effective biopharmaceutical products and solutions. This unique and crucial national initiative is a prerequisite to develop solutions for some of the unconquered diseases of India, and to sustain the future capabilities of our bio-economy and health system.
BIRAC has engaged the International AIDS Vaccine Initiative (IAVI) India for creating and facilitating processes and frameworks that will enable reaching a state of readiness by outlining the details for the roll-out of this Program. Significant progress has been made in this direction, and critical activities are underway that will aid in outlining a comprehensive proposal for this Program. These include detailing various operational and technical aspects of the Program such as: outlining modes for BIRAC to function as a Product Development Partnership (PDP) through its consortium of partners to ensure effective linkages and management to facilitate accelerated development and create an enabling environment; identification and prioritization (through data analysis and expert evaluation) of specific products and technology areas that should be supported through this Program in a milestone driven mode to support product and pipeline development.
In this direction, IAVI India is presently searching for a consultant to support the existing team in aiding the construct of the program. The position will be housed at IAVI’s India office in New Delhi.
The consultant would:
• Assist in qualitative research and analysis of biopharmaceutical products portfolio, (i.e., vaccines, monoclonal antibodies, therapeutic proteins, biosimilars) currently under development in India and globally;
• Work under the guidance of a network of national and international advisors/experts (from industry, academia and government) to aid in identifying and prioritizing product and technology development opportunities;
• Assist in writing the Program proposal.
Exemplary Skills Required:
• Evidence of scientific training ideally a life science-related PhD from a top institution. Would also consider undergraduate/graduate level studies with relevant work experience;
• Understanding of the biopharmaceutical sector, and preferably prior work experience and/or knowledge in related space;
• Strong understanding of the product development value chain, particularly for vaccines, monoclonal antibodies, therapeutic proteins, including biosimilars; and familiarity with skills, technologies, infrastructure critical for the same;
• Outstanding analytical skills; ability to do deep primary research, analyse and draw conclusions;
• Excellent organizational skills; strong interpersonal relationship skills; must have excellent communication skills - both written and verbal;
• Computer skills, including internet navigation and various office applications;
• Maturity and poise to interact with senior leaderships in industry and academia;
• Highly organized and proactive with a strong attention to detail and the ability to multitask; be quick on your feet and highly responsive;
• Enjoy both working independently and collaboratively in a small collegial team environment with honesty, integrity, intellectual curiosity.
The position provides a unique opportunity to participate in this Program of National significance and offers a competitive salary that will commiserate with the candidate’s experience. The position will be on contractual basis for an estimated period of six months with possibility of further opportunities based on Program needs. For immediate consideration, please e-mail a cover letter and resume to: firstname.lastname@example.org
BIRAC is an initiative by the Department of Biotechnology, Government of India, focused on empowering and enabling the biotech innovation ecosystem in the country for affordable product development. BIRAC’s mission is to stimulate, foster and enhance the strategic research and innovation capabilities of the Indian biotech industry to address the health needs of the largest section of society. While funding is a critical component, BIRAC is working towards strengthening the base of the pyramid (i.e., students and young entrepreneurs) by supporting novel ideas and taking them to proof-of-concept and then providing the essential support for early and late stage development right up to scale-up and commercialisation. More details at http://www.birac.nic.in/
IAVI is the world’s first bio-medical product development public-private partnership (PDP) that was launched in 1996 by the global community with a mission to ensure the development of safe, effective, preventive HIV vaccines, which would be accessible for use throughout the world. Headquartered in New York, IAVI is organised to conduct a global program integrating R&D, policy, and advocacy initiatives that engage researchers, policymakers, and civil society in 23 countries. IAVI’s India program was established in 2001, and has since then been orchestrating the creation of an effective framework for India to emerge as a regional centre of excellence for R&D in vaccines and other research tools and diagnostics that provide cost-effective solutions against HIV and other major global infectious diseases. More details at http://www.iavi.org/